Related references
Note: Only part of the references are listed.Structure-Based Virtual Screening for the Discovery of Novel Inhibitors of New Delhi Metallo-beta-lactamase-1
Francesca Spyrakis et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms
Domenico Schillaci et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase
Josephine P. Werner et al.
PROTEIN SCIENCE (2017)
Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases
Matteo Santucci et al.
SCIENTIFIC REPORTS (2017)
The challenge of antibiotic resistance in haematology patients
Ola Blennow et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Crystal Structures of KPC-2 and SHV-1 β-Lactamases in Complex with the Boronic Acid Transition State Analog S02030
Nhu Q. Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design
Laura J. Rojas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Decoding the Structural Basis For Carbapenem Hydrolysis By Class A beta-lactamases: Fishing For A Pharmacophore
Donatella Tondi et al.
CURRENT DRUG TARGETS (2016)
From An Enzyme Able to Destroy Penicillin to Carbapenemases: 70 Years of Beta-lactamase Misbehaviour
Jean-Marie Frere et al.
CURRENT DRUG TARGETS (2016)
Structural and Functional Aspects of Class A Carbapenemases
Thierry Naas et al.
CURRENT DRUG TARGETS (2016)
Oestrogen promotes healing in a bacterial LPS model of delayed cutaneous wound repair
Rachel Crompton et al.
LABORATORY INVESTIGATION (2016)
Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options
Elizabeth Cerceo et al.
MICROBIAL DRUG RESISTANCE (2016)
Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates
Juergen Brem et al.
NATURE COMMUNICATIONS (2016)
Interaction between lichen secondary metabolites and antibiotics against clinical isolates methicillin-resistant Staphylococcus aureus strains
Pierangelo Bellio et al.
PHYTOMEDICINE (2015)
The Inhibition of Extended Spectrum β-Lactamases: Hits and Leads
Davide Farina et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Targeting Class A and C Serine β-Lactamases with a Broad-Spectrum Boronic Acid Derivative
Donatella Tondi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The role of ligand efficiency metrics in drug discovery
Andrew L. Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Activity of biapenem (RPX2003) combined with the boronate -lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Automatic processing of macromolecular crystallography X-ray diffraction data at the ESRF
Stephanie Monaco et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2013)
Refining structures against reflection rank: an alternative metric for electron crystallography
Alexander S. Eggeman et al.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2012)
Crystal Structures of KPC-2 β-Lactamase in Complex with 3-Nitrophenyl Boronic Acid and the Penam Sulfone PSR-3-226
Wei Ke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
D. M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Structural study of phenyl boronic acid derivatives as AmpC beta-lactamase inhibitors
Donatella Tondi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Multidrug-resistant Gram-negative bacteria: how to treat and for how long
Helen Giamarellou
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination
Federico Perez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Patrice Nordmann et al.
LANCET INFECTIOUS DISEASES (2009)
Analysis of the plasticity of location of the Arg244 positive charge within the active site of the TEM-1 β-lactamase
David C. Marciano et al.
PROTEIN SCIENCE (2009)
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A β-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France
Stephanie Petrella et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Natural D240G Toho-1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43
Giuseppe Celenza et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy
Alberto Venturelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
David M. Livermore et al.
TRENDS IN MICROBIOLOGY (2006)
Structure-based design and in-parallel synthesis of inhibitors of AmpC β-lactamase
D Tondi et al.
CHEMISTRY & BIOLOGY (2001)
Share Paper
